awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38217623-08B2B9D5-64BC-4E0D-ACC3-B6EFB7390035
Q38217623-08B2B9D5-64BC-4E0D-ACC3-B6EFB7390035
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38217623-08B2B9D5-64BC-4E0D-ACC3-B6EFB7390035
Assessment of the metabolism of therapeutic proteins and antibodies.
P2860
Q38217623-08B2B9D5-64BC-4E0D-ACC3-B6EFB7390035
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38217623-08B2B9D5-64BC-4E0D-ACC3-B6EFB7390035
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6a43a09173e40107ad3c824b196233dfbe319daf
P2860
Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin.